Ignite Creation Date:
2024-05-06 @ 8:15 AM
Last Modification Date:
2024-10-26 @ 11:58 AM
Study NCT ID:
NCT02698735
Status:
COMPLETED
Last Update Posted:
2019-10-29
First Post:
2016-02-19
Brief Title:
Gentamicin Therapy for Recessive Dystrophic Epidermolysis Bullosa RDEB Nonsense Mutation Patients
Sponsor:
University of Southern California
Organization:
University of Southern California
Organization Data
Organization:
University of Southern California
Class:
OTHER
Study ID:
HS-15-00821
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Southern California
Lead Sponsor Class:
OTHER
Responsible Party:
David Woodley
Responsible Party Title:
Professor of Dermatology
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Southern California
Old Name:
None
Old Organization:
None